Evidence map›Paper›PMID 35883628›Full record

ArticleCells2022

The Succinate Receptor SUCNR1 Resides at the Endoplasmic Reticulum and Relocates to the Plasma Membrane in Hypoxic Conditions.

Melanie Sanchez, David Hamel, Emmanuel Bajon, François Duhamel, Vikrant K Bhosle, Tang Zhu, Jose Carlos Rivera, Rabah Dabouz, Mathieu Nadeau-Vallée, Nicholas Sitaras and 12 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Melanie SanchezDepartment of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada.
David HamelDepartment of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada.
Emmanuel BajonDepartment of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada.ORCID 0000-0002-1588-2953
François DuhamelDepartment of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada.
Vikrant K BhosleDepartment of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada.ORCID 0000-0002-2103-6454
Tang ZhuDepartment of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada.
Jose Carlos RiveraDepartment of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada.ORCID 0000-0003-2530-4433
Rabah DabouzDepartment of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada.
Mathieu Nadeau-ValléeDepartment of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada.
Nicholas SitarasDepartment of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada.
David-Étienne TremblayDepartment of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada.ORCID 0000-0002-9286-8434
Samy OmriDepartment of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada.
Tiffany HabelrihDepartment of Pharmacology, Université de Montréal, Montréal, QC H3C 3J7, Canada.
Raphael RougetDepartment of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada.
Xin HouDepartment of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada.
Fernand GobeilDepartment of Pharmacology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Jean-Sébastien JoyalDepartment of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada.
Przemyslaw SapiehaDepartment of Ophthalmology, Research Center of Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC H1T 2M4, Canada.
Grant MitchellDepartment of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada.
Alfredo Ribeiro-Da-SilvaDepartment of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada.
Mohammad Ali Mohammad NezhadyDepartment of Pediatrics, Research Center-CHU Ste-Justine, Montréal, QC H3T 1C5, Canada.
Sylvain ChemtobDepartment of Pharmacology and Therapeutics, McGill University, Montréal, QC H3A 1A3, Canada.
Centre Hospitalier Universitaire Sainte-Justine · CAUniversité de Montréal · CAMcGill University · CAHôpital Maisonneuve-Rosemont · CAHospital for Sick Children · CAUniversité de Sherbrooke · CA

Funding

CIHR
6 · The paper itself

Abstract

The GPCR SUCNR1/GPR91 exerts proangiogenesis upon stimulation with the Krebs cycle metabolite succinate. GPCR signaling depends on the surrounding environment and intracellular localization through location bias. Here, we show by microscopy and by cell fractionation that in neurons, SUCNR1 resides at the endoplasmic reticulum (ER), while being fully functional, as shown by calcium release and the induction of the expression of the proangiogenic gene for VEGFA. ER localization was found to depend upon N-glycosylation, particularly at position N8; the nonglycosylated mutant receptor localizes at the plasma membrane shuttled by RAB11. This SUCNR1 glycosylation is physiologically regulated, so that during hypoxic conditions, SUCNR1 is deglycosylated and relocates to the plasma membrane. Downstream signal transduction of SUCNR1 was found to activate the prostaglandin synthesis pathway through direct interaction with COX-2 at the ER; pharmacologic antagonism of the PGE

Indexed as

Receptors, G-Protein-CoupledSuccinic AcidAnimalsCell MembraneEndoplasmic ReticulumHypoxiaMiceSuccinatesReceptors, G-Protein-CoupledSuccinatesSuccinic Acidangiogenesisendoplasmic reticulumGPCRN-glycosylationsuccinateSUCNR1/GPR91

Identifiers

PMID35883628
PMCPMC9321536
OpenAlexW4285395429

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.